Medicare
Commentary
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Commentary
Democrats’ Obamacare Bailout Could Extend The Pandemic
This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis. But the legislation would ...
Business & Economics
NEW STUDY: Future Medical Innovation Will Be Hindered Unless Elected Officials Embrace Health Care Entrepreneurship
As Americans have benefited from tele-health and other innovations thanks to COVID-19 regulatory relief, future medical advances will be stymied unless policymakers remove road blocks that make it difficult for entrepreneurs to develop new technology and for patients to access it, finds the latest study in the Breaking Down Barriers ...
Commentary
Price controls punish U.S. innovators and economy
America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff it out by imposing ...
Health Care
Medicare for All and the COVID-19 Crisis
As single-payer advocates such as Senator Bernie Sanders (I-VT) and House member Alexandria Ocasio-Cortez (D-NY) are seizing on the COVID-19 pandemic to push even more aggressively for a complete takeover of our health care system by the federal government, listen to a special presentation of our recent webinar featuring PRI ...
Climate Change
Biden’s Mask Of Moderation Has Finally Slipped
Presumptive Democratic presidential nominee Joe Biden pitches himself to American voters as a reasonable and pragmatic centrist. But he’s stocked his campaign team with some of the Democratic party’s most prominent—and extreme—left-wingers. Last month, Biden announced the creation of several policy task forces designed to bring the party together. Those task ...
Commentary
Coronavirus Stimulus Would Barely Cover Medicare for All
The economic crisis caused by the coronavirus pandemic has prompted the biggest spending spree in American history. The House of Representatives just passed an additional relief package worth $3 trillion. That’s on top of $2.2 trillion in spending that Congress and the president green-lit in March — including $250 billion ...
Commentary
COVID-19 Reveals The Power Of Deregulation
One of the most effective policy responses to COVID-19 thus far has not been a new government program or infusion of federal funding. Rather, it’s been the deliberate effort by the Trump administration to pare back regulations impeding access to health care. That work must continue after the pandemic passes. ...
Commentary
Governor Newsom’s Medi-Cal Proposal Betrays California’s Poor
Governor Gavin Newsom just unveiled a new budget proposal aimed at digging California out of a $54 billion deficit brought on by the pandemic. He hopes to slash Medi-Cal payments to healthcare providers and use the money to enroll more people in the program. This week, the Democrat-led state legislature rejected those ...
Commentary
Coronavirus lockdown — How many harmed by disruption to routine medical care?
With states in the initial stages of reopening their economies, early research seems to indicate that the stay-at-home orders may not have had as much impact on the spread of COVID-19 as the conventional wisdom held. We may be on the cusp of a different “mass casualty incident,” a group of over 600 doctors ...
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Democrats’ Obamacare Bailout Could Extend The Pandemic
This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis. But the legislation would ...
NEW STUDY: Future Medical Innovation Will Be Hindered Unless Elected Officials Embrace Health Care Entrepreneurship
As Americans have benefited from tele-health and other innovations thanks to COVID-19 regulatory relief, future medical advances will be stymied unless policymakers remove road blocks that make it difficult for entrepreneurs to develop new technology and for patients to access it, finds the latest study in the Breaking Down Barriers ...
Price controls punish U.S. innovators and economy
America’s biopharmaceutical industry dwarfs most other economic sectors. It’s one of our nation’s single biggest job creators, supporting close to a million positions across the country. And its products save countless lives each year. Yet for some reason, politicians in both parties seem determined to snuff it out by imposing ...
Medicare for All and the COVID-19 Crisis
As single-payer advocates such as Senator Bernie Sanders (I-VT) and House member Alexandria Ocasio-Cortez (D-NY) are seizing on the COVID-19 pandemic to push even more aggressively for a complete takeover of our health care system by the federal government, listen to a special presentation of our recent webinar featuring PRI ...
Biden’s Mask Of Moderation Has Finally Slipped
Presumptive Democratic presidential nominee Joe Biden pitches himself to American voters as a reasonable and pragmatic centrist. But he’s stocked his campaign team with some of the Democratic party’s most prominent—and extreme—left-wingers. Last month, Biden announced the creation of several policy task forces designed to bring the party together. Those task ...
Coronavirus Stimulus Would Barely Cover Medicare for All
The economic crisis caused by the coronavirus pandemic has prompted the biggest spending spree in American history. The House of Representatives just passed an additional relief package worth $3 trillion. That’s on top of $2.2 trillion in spending that Congress and the president green-lit in March — including $250 billion ...
COVID-19 Reveals The Power Of Deregulation
One of the most effective policy responses to COVID-19 thus far has not been a new government program or infusion of federal funding. Rather, it’s been the deliberate effort by the Trump administration to pare back regulations impeding access to health care. That work must continue after the pandemic passes. ...
Governor Newsom’s Medi-Cal Proposal Betrays California’s Poor
Governor Gavin Newsom just unveiled a new budget proposal aimed at digging California out of a $54 billion deficit brought on by the pandemic. He hopes to slash Medi-Cal payments to healthcare providers and use the money to enroll more people in the program. This week, the Democrat-led state legislature rejected those ...
Coronavirus lockdown — How many harmed by disruption to routine medical care?
With states in the initial stages of reopening their economies, early research seems to indicate that the stay-at-home orders may not have had as much impact on the spread of COVID-19 as the conventional wisdom held. We may be on the cusp of a different “mass casualty incident,” a group of over 600 doctors ...
